Kidnex Iv Liquid
NDC Package 44911-0747-1
Package Information
Kidnex Iv (ginkgo biloba, alpha-ketoglutaricum acidum, citricum acidum, fumaricum acidum, malicum acidum, pyruvic acid, succinicum acidum, argentum metallicum, aurum metallicum, cuprum metallicum, germanium sesquioxide, mercurius vivus, nux vomica, kidney (suis), lymph node (suis), naphthochinonum, natrum oxalaceticum, phosphorus, urinary bladder (suis), aconiticum acidum, cis-) liquids is adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. This formulation utilizes a liquid delivery system. Marketed by Energique, Inc., this product is identified by NDC 44911-0747.
Identification & Billing
Clinical Specifications
- 1,4-NAPHTHOQUINONE 12 [hp_X]/mL
- ACONITIC ACID, (Z)- 30 [hp_X]/mL
- ANHYDROUS CITRIC ACID 8 [hp_X]/mL
- COPPER 12 [hp_X]/mL
- FUMARIC ACID 8 [hp_X]/mL
- GERMANIUM SESQUIOXIDE 12 [hp_X]/mL
- GINKGO 6 [hp_X]/mL
- GOLD 12 [hp_X]/mL
- MALIC ACID 8 [hp_X]/mL
- MERCURY 12 [hp_X]/mL
- OXOGLURIC ACID 8 [hp_X]/mL
- PHOSPHORUS 12 [hp_X]/mL
- PORK KIDNEY 12 [hp_X]/mL
- PYRUVIC ACID 8 [hp_X]/mL
- SILVER 12 [hp_X]/mL
- SODIUM DIETHYL OXALACETATE 12 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED 12 [hp_X]/mL
- SUCCINIC ACID 8 [hp_X]/mL
- SUS SCROFA LYMPH 12 [hp_X]/mL
- SUS SCROFA URINARY BLADDER 12 [hp_X]/mL
- Acidifying Activity - [MoA] (Mechanism of Action)
- Allergens - [CS]
- Anti-coagulant - [EPC] (Established Pharmacologic Class)
- Calcium Chelating Activity - [MoA] (Mechanism of Action)
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Copper - [CS]
- Copper-containing Intrauterine Device - [EPC] (Established Pharmacologic Class)
- Decreased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Decreased Embryonic Implantation - [PE] (Physiologic Effect)
- Decreased Sperm Motility - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Inhibit Ovum Fertilization - [PE] (Physiologic Effect)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
- Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 44911 - Energique, Inc.
- 44911-0747 - Kidnex Iv
- 44911-0747-1 - 30 mL in 1 BOTTLE, DROPPER
- 44911-0747 - Kidnex Iv
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 44911-0747-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Kidnex Iv, a human over the counter drug labeled by Energique, Inc.. This liquid is formulated for oral use and contains 1,4-naphthoquinone; aconitic acid, (z)-; anhydrous citric acid; copper; fumaric acid; germanium sesquioxide; ginkgo; gold; malic acid; mercury; oxogluric acid; phosphorus; pork kidney; pyruvic acid; silver; sodium diethyl oxalacetate; strychnos nux-vomica seed; succinic acid; sus scrofa lymph; sus scrofa urinary bladder as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energique, Inc. on February 26, 2026. The current certification is valid through December 31, 2027.
How is this Energique, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 44911074701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.